YH ENT (02306) spent 47,600 Hong Kong dollars on February 12 to repurchase 75,000 shares.

12/02/2025

GMT Eight

YH ENT (02306) announced that on February 12, 2025, the company invested HKD 47,600 to repurchase 75,000 shares at a repurchase price of HKD 0.62-0.64 per share.

Dezhan Healthcare's affiliated company Dongfang Lue has received approval for clinical trials for a new indication in a collaborative research and development project.

Chen Meibao: The Hong Kong Special Administrative Region Government will continue to promote the development of the low-altitude economy in various ways.

Contact: contact@gmteight.com

YH ENT (02306) spent 47,600 Hong Kong dollars on February 12 to repurchase 75,000 shares.

RECOMMEND

US Stock Market Move | Youdao Inc ADR Class A(DAO.US) rose more than 12% after announcing full adoption of DeepSeek-R1.

Sws Hemodialysis Care (688410.SH) shareholders Zhuhai Xiu Heng intend to reduce their stake by no more than 2.92%.

US Stock Market Move | The outlook for Q1 bookings is not good, Lyft Inc (LYFT.US) fell more than 7%.